Kos Parmaceuticals News
Most Popular Kos Parmaceuticals Story
Biotech entrepreneur turns talents to venture fund
The Wall Street Journal offers an in-depth look at Michael Jaharis, a noted biotech entrepreneur who recently sold Kos Pharmaceuticals... Read more...
Latest Headlines
- August 15, 2007
- November 8, 2006
- November 5, 2006
- September 21, 2006
- December 15, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
